Cargando…
Nevirapine Increases Sodium/Iodide Symporter-Mediated Radioiodide Uptake by Activation of TSHR/cAMP/CREB/PAX8 Signaling Pathway in Dedifferentiated Thyroid Cancer
Nevirapine has been proved to be effective in inducing re-differentiation and suppressing tumor growth in several tumor cells. This study aims to investigate the therapeutic potential of nevirapine in dedifferentiated thyroid cancer (DeTC), which refractory to radioiodine treatment and the underlyin...
Autores principales: | Shang, Hongxia, Zhao, Junyu, Yao, Jinming, Wang, Huanjun, Dong, Jianjun, Liao, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145398/ https://www.ncbi.nlm.nih.gov/pubmed/32300552 http://dx.doi.org/10.3389/fonc.2020.00404 |
Ejemplares similares
-
Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells
por: Shang, Hongxia, et al.
Publicado: (2019) -
Baculovirus Vector-Mediated Transfer of Sodium Iodide Symporter and Plasminogen Kringle 5 Genes for Tumor Radioiodide Therapy
por: Zhang, Min, et al.
Publicado: (2014) -
Implications of Na(+)/I(-) Symporter Transport to the Plasma Membrane for Thyroid Hormonogenesis and Radioiodide Therapy
por: Martín, Mariano, et al.
Publicado: (2018) -
Dimerization of the Sodium/Iodide Symporter
por: Thompson, Rebecca J., et al.
Publicado: (2019) -
Congenital Hypothyroidism Caused by a PAX8 Gene Mutation Manifested as Sodium/Iodide Symporter Gene Defect
por: Jo, Wakako, et al.
Publicado: (2009)